<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="80801">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02053480</url>
  </required_header>
  <id_info>
    <org_study_id>P00010515</org_study_id>
    <nct_id>NCT02053480</nct_id>
  </id_info>
  <brief_title>Pyruvate Kinase Deficiency Natural History Study</brief_title>
  <acronym>PKD NHS</acronym>
  <official_title>Pyruvate Kinase Deficiency (PKD) Natural History Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agios Pharmaceuticals, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston Children’s Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to describe the range and incidence of symptoms, treatments,
      and complications related to pyruvate kinase deficiency (PKD). Eligible patients are those
      of all ages with known PKD or with a hemolytic anemia and a family member with PKD. The
      study will collect retrospective medical history, routine clinical care data, and quality of
      life measures at baseline and annually for patients with PKD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the Pyruvate Kinase Deficiency (PKD) Natural History Study is to describe the
      natural history of PKD and the range and incidence of symptoms, treatments, and
      complications related to PKD. The study will collect retrospective medical history and
      routine clinical care data at baseline and annually for patients with PKD. Patients without
      a genetic diagnosis will have a blood sample drawn for genetic diagnostic confirmation for
      research purposes. Understanding the clinical variation among participants with PKD, and
      assessing treatments specific to PKD and their outcomes will accelerate improvement in the
      care of patients with PKD. Understanding the natural history of PKD may be useful in the
      design of future interventional studies. Detailed genotypic and phenotypic characterization
      of the cohort will allow for continued in depth characterization of PKD. Finally, the PKD
      Natural History Study will identify interested participants for future PKD studies.

      Primary Objectives:

        1. To estimate the transfusion burden in splenectomized and non-splenectomized
           participants with PKD.

        2. To establish a patient registry as a potential source for recruitment to future
           research studies in PKD.

      Secondary Objectives:

        1. To determine if patient-reported outcomes, including quality of life and fatigue
           scales, are associated with age, genotype, hemoglobin nadir, and/or transfusion burden,
           overall and within the subgroups of splenectomized vs. non-splenectomized participants;

        2. To describe changes over time in the range of hemoglobin values and markers of
           hemolysis within individual participants and among participants with PKD;

        3. To estimate the incidence of past splenectomy and annual splenectomy rate, as treatment
           for PKD;

        4. To estimate the prevalence and severity and describe the treatment of hepatic and
           cardiac iron overload and its complications in PKD (liver, cardiac, growth defects,
           hypogonadotropic hypogonadism, and other endocrine defects). To describe the changes in
           these complications that may occur over time and by age group;

        5. To estimate the prevalence of co-morbidities associated with chronic hemolysis in PKD,
           to identify which co-morbidities are the most common, and to determine if the
           prevalence and/or severity of co-morbidities change over time and by age at the time of
           the first appearance of the co-morbidity;

        6. To determine pregnancy outcomes among participants with PKD;

        7. To describe genotypic and phenotypic variation among participants and explore
           genotype-phenotype correlation in PKD.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>transfusion burden in splenectomized and non-splenectomized participants</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>patient-reported outcomes</measure>
    <time_frame>enrollment, annually, up to 2 years</time_frame>
    <description>EuroQoL-5D-5L, Functional Assessment of Cancer Therapy-Anemia (FACT-An), Pediatric Quality of Life Inventory 4.0 (pedsQL 4.0), Pediatric Functional Assessment of Chronic Illness-Fatigue (pedsFACIT-F), Patient Reported Outcomes Measurement Information System Fatigue (PROMIS Fatigue)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>changes over time in hemoglobin and markers of hemolysis</measure>
    <time_frame>enrollment, annually, up to 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>prevalence and severity of iron overload</measure>
    <time_frame>enrollment, annually, up to 2 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Pyruvate Kinase Deficiency</condition>
  <condition>Congenital Non-Spherocytic Hemolytic Anemia</condition>
  <arm_group>
    <arm_group_label>Pyruvate Kinase Deficiency</arm_group_label>
    <description>Patients of all ages with Pyruvate Kinase Deficiency</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Pyruvate Kinase Deficiency of all ages
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients of all ages with biochemically or genetically diagnosed PKD.

          -  Patients with a hemolytic anemia AND a family member with genetically diagnosed PKD

          -  The participant or the guardian of the participant is willing and able to give
             written informed consent and/or assent.

        Exclusion Criteria:

          -  The participant or the guardian of the participant is unwilling or unable to give
             written informed consent and/or assent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rachael F Grace, MD, MMSc</last_name>
    <phone>617-632-3528</phone>
    <email>Rachael.Grace@childrens.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nolan Neu, BS</last_name>
    <phone>617-919-6863</phone>
    <email>Nolan.Neu@childrens.harvard.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Phoenix Children's Hospital</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erica Olson, RN</last_name>
      <phone>602-933-0171</phone>
      <email>eolson1@phoenixchildrens.com</email>
    </contact>
    <investigator>
      <last_name>Christine Knoll, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Hilmoe, CRA</last_name>
      <phone>650-725-1662</phone>
      <email>hhilmoe@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Bertil Glader, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lurie Children's Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaclyn Janoski, BS, MS,CCRP</last_name>
      <phone>312-227-9372</phone>
      <email>JJanoski@luriechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Alexis Thompson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nolan Neu, BS</last_name>
      <phone>617-919-6863</phone>
      <email>Nolan.Neu@childrens.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Rachael F Grace, MD, MMSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Massachusetts Medical Center</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01605</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Danielle Pinchette, CRA</last_name>
      <phone>508-856-3077</phone>
      <email>Danielle.Pichette-Patsky@umassmed.edu</email>
    </contact>
    <investigator>
      <last_name>Peter Newburger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wayne State University School of Medicine</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charmaine Williams-Farr, MA, CRC</last_name>
      <phone>313-745-4276</phone>
      <email>CWilliam8@dmc.org</email>
    </contact>
    <investigator>
      <last_name>Yaddanapudi Ravindranath, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dana Johnson Cole, RN, CPON</last_name>
      <phone>601-984-2712</phone>
      <email>dajohnson@umc.edu</email>
    </contact>
    <investigator>
      <last_name>Melissa Rhodes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Mercy Hospitals &amp; Clinics</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eryn Bilynsky, RN, CCRC</last_name>
      <phone>816-302-6853</phone>
      <email>erbilynsky@cmh.edu</email>
    </contact>
    <investigator>
      <last_name>Mukta Sharma, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miranda Payan</last_name>
      <phone>646-962-9317</phone>
      <email>mip2033@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Patricia Giardina, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hai Huang, MD</last_name>
      <phone>919-613-4676</phone>
      <email>h.hai@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Jennifer Rothman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heidi Ziegler</last_name>
      <phone>614-722-3883</phone>
      <email>Heidi.Ziegler@nationwidechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Melissa Rose, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DDC Clinic for Special Needs Children</name>
      <address>
        <city>Middlefield</city>
        <state>Ohio</state>
        <zip>44062</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerie Sency, RN</last_name>
      <phone>440-632-1668</phone>
      <email>Valerie@ddcclinic.org</email>
    </contact>
    <investigator>
      <last_name>Heng Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abinaya Arulselvan</last_name>
      <phone>215-590-3582</phone>
      <email>ARULSELVAA@EMAIL.CHOP.EDU</email>
    </contact>
    <investigator>
      <last_name>Janet Kwiatkowski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Central Pennsylvania Clinic</name>
      <address>
        <city>Strasburg</city>
        <state>Pennsylvania</state>
        <zip>17579</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Morton</last_name>
      <phone>413-512-1316</phone>
      <email>paulmorton150@comcast.net</email>
    </contact>
    <investigator>
      <last_name>D. Holmes Morton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Jude Children's Research Hospital</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Brown, MPH</last_name>
      <phone>901-595-6411</phone>
      <email>ashley.brown@stjude.org</email>
    </contact>
    <investigator>
      <last_name>Winfred Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheryl Nelson</last_name>
      <phone>832-824-1502</phone>
      <email>sxnelson@texaschildrens.org</email>
    </contact>
    <investigator>
      <last_name>Jenny Despotovic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kolenya Holly, MPH</last_name>
      <phone>801-587-7463</phone>
      <email>Kolenya.Holly@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Hassan Yaish, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Vermont College of Medicine &amp; University of Vermont Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathryn Murray, BS, CCRC</last_name>
      <phone>802-656-9913</phone>
      <email>Kathryn.Murray@med.uvm.edu</email>
    </contact>
    <investigator>
      <last_name>Heather Bradeen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McMaster University</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 3Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Nagel, RN, MHSc(N)</last_name>
      <phone>905-521-2100</phone>
      <phone_ext>76054</phone_ext>
      <email>nagel@hhsc.ca</email>
    </contact>
    <investigator>
      <last_name>Vicky Breakey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Health Network</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Dzyuba, CCRP</last_name>
      <phone>416-340-4800</phone>
      <phone_ext>4628</phone_ext>
      <email>maria.dzyuba@uhn.ca</email>
    </contact>
    <investigator>
      <last_name>Kevin Kuo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Sainte-Justine</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3T 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne-Julie Landry, M.Sc, DESS</last_name>
      <phone>514-345-4931</phone>
      <phone_ext>6471</phone_ext>
      <email>anne-julie.landry@recherche-ste-justine.qc.ca</email>
    </contact>
    <investigator>
      <last_name>Yves Pastore, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Freiburg</name>
      <address>
        <city>Freiburg</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Wirth</last_name>
      <phone>0761 270-46980</phone>
      <email>barbara.wirth@uniklinik-freiburg.de</email>
    </contact>
    <investigator>
      <last_name>Marcin Wlodarski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UniversitätsKlinikum Heidelberg, Zentrum für Kinder- und Jugendmedizin Klinik Kinderheilkunde III</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>Joachim.Kunz@med.uni-heidelberg.de</email>
    </contact>
    <investigator>
      <last_name>Joachim Kunz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Kassel</name>
      <address>
        <city>Kassel</city>
        <zip>34125</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nina Kollmar, MD</last_name>
      <email>kollmar@klinikum-kassel.de</email>
    </contact>
    <investigator>
      <last_name>Nina Kollmar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universität München, Center for Pediatric Hematology/Hemostaseology</name>
      <address>
        <city>Munich</city>
        <zip>80337</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>08-97140975</phone>
      <email>praxis@kid-z.de</email>
    </contact>
    <contact_backup>
      <email>Kind-im-zentrum@t-online.de</email>
    </contact_backup>
    <investigator>
      <last_name>Stefan Eber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milan</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eleonora Ferretti</last_name>
      <phone>02-55033469</phone>
      <email>eleonora.ferretti@policlinico.mi.it</email>
    </contact>
    <investigator>
      <last_name>Wilma Barcellini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UMC Utrecht</name>
      <address>
        <city>Utrecht</city>
        <zip>3508GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie van Straaten</last_name>
      <phone>+31 88 75 584 50</phone>
      <email>H.A.S.vanStraaten-3@umcutrecht.nl</email>
    </contact>
    <investigator>
      <last_name>Eduard J van Beers, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 30, 2017</lastchanged_date>
  <firstreceived_date>January 28, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Children's Hospital</investigator_affiliation>
    <investigator_full_name>Rachael Grace</investigator_full_name>
    <investigator_title>Principal Investigator, PKD Natural History Study</investigator_title>
  </responsible_party>
  <keyword>pyruvate kinase deficiency</keyword>
  <keyword>hemolytic anemia</keyword>
  <keyword>anemia</keyword>
  <keyword>enzymopathy</keyword>
  <keyword>jaundice</keyword>
  <keyword>splenectomy</keyword>
  <keyword>health-related quality of life</keyword>
  <keyword>Hematologic diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Hemolysis</mesh_term>
    <mesh_term>Anemia, Hemolytic</mesh_term>
    <mesh_term>Anemia, Hemolytic, Congenital Nonspherocytic</mesh_term>
    <mesh_term>Pyruvate Metabolism, Inborn Errors</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
